All Publications Citing Use of MCE Products

• Clin Cancer Res. 2021 Apr 1;27(7):1855-1863. Palbociclib, Angiopoietin-2 Protein, Human (222a.a, HEK293, His) purchased from MCE.

• Adv Healthc Mater. 2020, 2001029. PRIMA-1 purchased from MCE.

• Adv Healthc Mater. 2020 Nov;9(22):e2001633. Doxorubicin hydrochloride purchased from MCE.

• Clin Cancer Res. 2020 Nov 15;26(22):5962-5973. Sotorasib, ARS-1620, IL-6 Protein, Rat (HEK293) purchased from MCE.

• Clin Cancer Res. 2020 Aug 15;26(16):4349-4359. Imatinib purchased from MCE.

• Clin Cancer Res. 2020 Jul 1;26(13):3431-3442. PD0166285, Adavosertib purchased from MCE.

• Clin Cancer Res. 2020 Jun 1;26(11):2615-2625. Merestinib purchased from MCE.

• Clin Cancer Res. 2020 Apr 15;26(8):2011-2021. Mirdametinib, Selumetinib, PIK-75 hydrochloride, Mocetinostat, Simvastatin, Doxorubicin, Triptolide, Apitolisib, PI-103, Rapamycin, Daunorubicin, CI-1040, Entinostat, Flavopiridol, GRO-gamma/CXCL3 Protein, Human (CHO), FCGRT-B2M Heterodimer Protein, Cynomolgus (HEK293, Flag-His) purchased from MCE.

• Clin Cancer Res. 2019 Dec 1;25(23):7139-7150. WEHI-539 purchased from MCE.

• Clin Cancer Res. 2020 Apr 1;26(7):1633-1643. Sotorasib, ARS-1620, IL-6 Protein, Rat (HEK293) purchased from MCE.

• Clin Cancer Res. 2019 Oct 15;25(20):6127-6140. Olaparib purchased from MCE.

• Clin Cancer Res. 2019 Oct 15;25(20):6195-6205. THZ1 purchased from MCE.

• Adv Healthc Mater. 2019 Sep;8(18):e1900543. Mitomycin C, Doxorubicin purchased from MCE.

• Clin Cancer Res. 2019 Jul 1;25(13):4128-4140. EC330 purchased from MCE.

• Clin Cancer Res. 2019 Jul 15;25(14):4552-4566. PF-562271, Barasertib, PND-1186 purchased from MCE.

• Clin Cancer Res. 2019 Jul 15;25(14):4455-4465. Venetoclax, S63845 purchased from MCE.

• Clin Cancer Res. 2019 Jul 1;25(13):4179-4193. Alisertib purchased from MCE.

• Clin Cancer Res. 2019 Jun 15;25(12):3630-3642. Bortezomib purchased from MCE.

• Clin Cancer Res. 2019 Jun 1;25(11):3404-3416. (+)-JQ-1, ARV-771, ARV-825, CYBB/Nox2 Protein, Human (His) purchased from MCE.

• Clin Cancer Res. 2019 Feb 1;25(3):1070-1086. CP-673451, IFN-lambda 1/IL-29 Protein, Human purchased from MCE.

• Clin Cancer Res. 2018 Nov 1;24(21):5458-5470. S63845 purchased from MCE.

• Clin Cancer Res. 2018 Sep 1;24(17):4256-4270. Silvestrol purchased from MCE.

• Clin Cancer Res. 2018 Nov 15;24(22):5645-5657. OTSSP167 hydrochloride purchased from MCE.

• Clin Cancer Res. 2019 Jul 1;25(13):4079-4090. Telaglenastat purchased from MCE.

• Clin Cancer Res. 2018 Apr 1;24(7):1705-1715. AGI-6780, AGI-5198 purchased from MCE.

• Clin Cancer Res. 2018 Apr 15;24(8):1917-1931. Ruxolitinib, AZD-1480 purchased from MCE.

• Clin Cancer Res. 2018 Mar 1;24(5):1103-1113. Idelalisib purchased from MCE.

• Clin Cancer Res. 2018 Feb 15;24(4):794-806. Luminespib purchased from MCE.

• Clin Cancer Res. 2018 Mar 1;24(5):1176-1189. Sotuletinib, Cytochrome C Antibody (YA5422) purchased from MCE.

• Clin Cancer Res. 2018 Jan 15;24(2):383-394. Elacridar purchased from MCE.

• Clin Cancer Res. 2017 Nov 1;23(21):6529-6540. CX-5461 purchased from MCE.

• Clin Cancer Res. 2017 Nov 15;23(22):6923-6933. Enzalutamide purchased from MCE.

• Clin Cancer Res. 2017 Feb 15;23(4):1001-1011. Niraparib, Talazoparib, Rucaparib, Veliparib, Iniparib, Olaparib, AZD-2461, TNF-alpha/TNFSF2 Protein, Human (His), Phospho-c-Jun(Ser63) Antibody (YA214) purchased from MCE.

• Clin Cancer Res. 2016 Nov 15;22(22):5514-5526. Uprosertib purchased from MCE.

• Clin Cancer Res. 2016 Mar 1;22(5):1185-96. RG7112 purchased from MCE.

• Clin Cancer Res. 2015 Nov 1;21(21):4845-55. Enzalutamide purchased from MCE.

• Clin Cancer Res. 2015 Nov 1;21(21):4947-59. Ribociclib hydrochloride, Ribociclib purchased from MCE.

• Clin Cancer Res.  2015 Oct 15;21(20):4642-51. Firategrast purchased from MCE.

• Clin Cancer Res. 2015 Apr 1;21(7):1675-87. Enzalutamide purchased from MCE.

• Clin Cancer Res. 2014 Dec 15;20(24):6367-78. Enzalutamide purchased from MCE.

• Clin Cancer Res. 2014 Dec 1;20(23):6034-44. Selumetinib, FCGRT-B2M Heterodimer Protein, Cynomolgus (HEK293, Flag-His) purchased from MCE.

• Clin Cancer Res. 2014 Nov 1;20(21):5483-95. Mirdametinib, ZSTK474, Trametinib, AZD8330, Selumetinib, PI-103, GSK1904529A, Omipalisib, FGF-8e Protein, Human, FCGRT-B2M Heterodimer Protein, Cynomolgus (HEK293, Flag-His), MSP/MST1 Protein, Mouse (C677A, HEK293), Fibrinogen β Antibody (YA4854) purchased from MCE.

• Clin Cancer Res. 2013 Feb 1;19(3):598-609. Vemurafenib purchased from MCE.

• J Natl Cancer Inst. 2024 Dec 11:djae329. Raleukin purchased from MCE.

• J Natl Cancer Inst. 2023 Jul 22;djad142. Pyridostatin, Osimertinib, Torin 1 purchased from MCE.

• Euro Surveill. 2019 Mar;24(12):1900170. Baloxavir marboxil purchased from MCE.

• EBioMedicine. 2025 Feb 15:113:105599. D-Lin-MC3-DMA purchased from MCE.

• EBioMedicine. 2025 Jan 13:112:105533. Acetylcysteine purchased from MCE.

• EBioMedicine. 2024 Jul. 5-Azacytidine, CPI-455, Palbociclib, Angiopoietin-2 Protein, Human (222a.a, HEK293, His) purchased from MCE.

• EBioMedicine. 2024 Oct 8:109:105390. Y-27632, Lymphocyte antigen 6A-2/LY6A Protein, Mouse (His) purchased from MCE.